Lorenz U, Bergemann A D, Steinberg H N, Flanagan J G, Li X, Galli S J, Neel B G
Molecular Medicine Unit, Beth Israel Hospital, Boston, Massachusetts, USA.
J Exp Med. 1996 Sep 1;184(3):1111-26. doi: 10.1084/jem.184.3.1111.
Receptor protein tyrosine kinases (RTKs) transmit downstream signals via interactions with secondary signaling molecules containing SH2 domains. Although many SH2-phosphotyrosyl interactions have been defined in vitro, little is known about the physiological significance of specific RTK/SH2 interactions in vivo. Also, little is known about the mechanisms by which specific RTKs interact with and/or are regulated by specific protein tyrosine phosphatases (PTPs). To address such issue, we carried out a genetic analysis of the previously reported biochemical interaction between the RTK c-Kit, encoded at the W locus, and the SH2-containing non-transmembrane PTP SHP1, encoded at the motheaten (me) locus (1). Mice carrying a kinase-defective allele of c-Kit (Wv/+) were crossed with me/+ mice, which carry one effectively null allele of SHP1, and then backcrossed to generate all possible allelic combinations. Our results indicate strong intergenic complementation between these loci in hematopoietic progenitor cells. Compared to progenitors purified from normal mice, bone marrow progenitor cells (lin-) from me/me mice markedly hyper-proliferated in response to Kit ligand (KL). stimulation. Superimposition of the me/me genotype increased the number of one marrow-derived CFU-E from Wv/+ mice. Conversely, the presence of one or two copies of Wv decreased the number of macrophages and granulocytes in me/me lung, skin, peripheral blood and bone marrow, thereby decreasing the severity of the me/me phenotype. The decrease in dermal mast cells in Wv/Wv mice was rescued to levels found in Wv/+mice by superimposition of the me/me genotype. Surprisingly, however, the presence or absence of SHP1 had no effect on the proliferative response of bone marrow-derived cultured mast cells to KL or IL3 ex vivo. Nevertheless, the immediate-early response to KL stimulation, as measured by KL-induced tyrosyl phosphorylation, was substantially increased in mast cells from Wv/+:me/me compared to Wv/ +:+/+ mice, strongly suggesting that SHP1 directly dephosphorylates and regulates c-Kit. Taken together, our results establish that SHP1 negatively regulates signaling from c-Kit in vivo, but in a cell type-specific manner.
受体蛋白酪氨酸激酶(RTK)通过与含有SH2结构域的二级信号分子相互作用来传递下游信号。尽管许多SH2-磷酸酪氨酸相互作用已在体外得到明确,但对于体内特定RTK/SH2相互作用的生理意义却知之甚少。此外,关于特定RTK与特定蛋白酪氨酸磷酸酶(PTP)相互作用和/或受其调节的机制也了解甚少。为了解决这个问题,我们对先前报道的位于W位点编码的RTK c-Kit与位于动食(me)位点编码的含SH2的非跨膜PTP SHP1之间的生化相互作用进行了遗传分析(1)。携带c-Kit激酶缺陷等位基因(Wv/+)的小鼠与携带SHP1一个有效无效等位基因的me/+小鼠杂交,然后回交以产生所有可能的等位基因组合。我们的结果表明这些位点在造血祖细胞中存在强烈的基因间互补作用。与从正常小鼠纯化的祖细胞相比,来自me/me小鼠的骨髓祖细胞(lin-)对Kit配体(KL)刺激有明显的过度增殖。me/me基因型的叠加增加了来自Wv/+小鼠的骨髓源性CFU-E的数量。相反,一个或两个Wv拷贝的存在减少了me/me小鼠肺、皮肤、外周血和骨髓中巨噬细胞和粒细胞的数量,从而减轻了me/me表型的严重程度。通过叠加me/me基因型,Wv/Wv小鼠皮肤肥大细胞的减少得以恢复到Wv/+小鼠中的水平。然而,令人惊讶的是,SHP1的存在与否对体外培养的骨髓肥大细胞对KL或IL3的增殖反应没有影响。尽管如此,与Wv/+:+/+小鼠相比,Wv/+:me/me小鼠肥大细胞中由KL诱导的酪氨酰磷酸化所测量的对KL刺激的早期即时反应显著增加,这强烈表明SHP1直接使c-Kit去磷酸化并对其进行调节。综上所述,我们的结果表明SHP1在体内对c-Kit信号传导起负调节作用,但具有细胞类型特异性。